Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 8795213, 3 pages
https://doi.org/10.1155/2017/8795213
Case Report

Systemic Amyloidosis and Cardiac Autonomic Neuropathy Associated with Waldenstrom’s Macroglobulinemia

Department of Internal Medicine, Monmouth Medical Center, 300 2nd Ave, Long Branch, NJ 07740, USA

Correspondence should be addressed to Aasems Jacob; moc.liamg@jsmesaa

Received 11 March 2017; Accepted 23 May 2017; Published 13 June 2017

Academic Editor: Marie-Christine Kyrtsonis

Copyright © 2017 Aasems Jacob et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. García-Sanz, S. Montoto, A. Torrequebrada, A. García De Coca, J. Petit, A. Sureda et al., “Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases,” British Journal of Haematology, vol. 115, no. 3, pp. 575–582, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Yood, M. Skinner, A. Rubinow, L. Talarico, and A. S. Cohen, “Bleeding manifestations in 100 patients with amyloidosis,” The Journal of the American Medical Association, vol. 249, no. 10, pp. 1322–1324, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Ewing, C. N. Martyn, R. J. Young, and B. F. Clarke, “The value of cardiovascular autonomic function tests: 10 years experience in diabetes,” Diabetes Care, vol. 8, no. 5, pp. 491–498, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Kyle and M. A. Gertz, “Systemic amyloidosis,” Critical Reviews in Oncology/Hematology, vol. 10, no. 1, pp. 49–87, 1990. View at Publisher · View at Google Scholar
  5. J. Julien, C. Vital, J. M. Vallat et al., “IgM Demyelinative neuropathy with amyloidosis and biclonal gammopathy,” Annals of Neurology, vol. 15, no. 4, pp. 395–399, 1984. View at Publisher · View at Google Scholar · View at Scopus
  6. D. B. Stevens and G. H. Whitehouse, “Waldenstrom's macroglobulinaemia with amyloidosis; lymphographic findings,” Lymphology, vol. 9, article 34, pp. 142–144, 1976. View at Google Scholar · View at Scopus
  7. B. Terrier, A. Jaccard, J.-L. Harousseau et al., “The clinical spectrum of IgM-related amyloidosis: A french nationwide retrospective study of 72 patients,” Medicine, vol. 87, no. 2, pp. 99–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. W. Dubrey, K. Cha, J. Anderson et al., “The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement,” Oxford Journals Medicine, vol. 91, no. 2, pp. 141–157, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Stratogianni, M. Tosch, and H. Schlemmer, “Bortezomib-induced severe autonomic neuropathy,” Clinical Autonomic Research, vol. 22, no. 4, pp. 199–202, 2012. View at Publisher · View at Google Scholar
  10. S. W. Dubrey, K. Cha, R. W. Simms, M. Skinner, and R. H. Falk, “Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis,” American Journal of Cardiology, vol. 77, no. 4, pp. 313–315, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Rapezzi, C. C. Quarta, L. Riva et al., “Transthyretin-related amyloidoses and the heart: a clinical overview,” Nature Reviews Cardiology, vol. 7, no. 7, pp. 398–408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Unnikrishnan, A. Jacob, M. Anthony Diaz, and J. Lederman, “Silent myocardial infarction secondary to cardiac autonomic neuropathy in a patient with rheumatoid arthritis,” BMJ Case Reports, vol. 2016, Article ID 215257, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. I. Vinik and T. Erbas, “Diabetic autonomic neuropathy,” Handbook of Clinical Neurology, vol. 117, pp. 27–294, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Zander, B. Schulz, P. Heinke, E. Grimmberger, G. Zander, and H. D. Gottschling, “Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy,” Diabetes Care, vol. 12, no. 4, pp. 259–264, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Stevens, M. E. Edmonds, C. J. Mathias, and P. J. Watkins, “Disabling postural hypotension complicating diabetic autonomic neuropathy,” Diabetic Medicine, vol. 8, no. 9, pp. 870–874, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. M. M. Jansen and L. A. Lipsitz, “Postprandial hypotension: Epidemiology, pathophysiology, and clinical management,” Annals of Internal Medicine, vol. 122, no. 4, pp. 286–295, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Stranieri, J. Abawajy, A. Kelarev, S. Huda, M. Chowdhury, and H. F. Jelinek, “An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy,” Artificial Intelligence in Medicine, vol. 58, no. 3, pp. 185–193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Freeman, “Neurogenic orthostatic hypotension,” The New England Journal of Medicine, vol. 358, no. 6, pp. 615–624, 2008. View at Publisher · View at Google Scholar · View at Scopus